🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multicenter, Phase II clinical study to evaluate the...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-20
Trial ID
NCT07742956
Treatments Being Tested
To evaluate the efficacy and safety of anlotinib combined with TQB2450 and ...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2023-06-07
Trial ID
NCT06939452
Treatments Being Tested
This is a non-interventional, multi-country, multi-centre, multiple cohort ...
Status
Completed
Location
Hospital Universitario Austral
Start Date
2019-02-07
Trial ID
NCT03782207
Treatments Being Tested
Several reports have examined Programmed Death 1 (PD-1) expression on tumor...
Status
Unknown
Location
Instituto National de Cancerologia
Start Date
2017-03
Trial ID
NCT02758314
Treatments Being Tested
This is a single arm, prospective, interventional, multicenter phase 2 stud...
Status
Unknown
Location
AOU San Luigi- Department of Oncology
Start Date
2020-12-23
Trial ID
NCT04940637
Treatments Being Tested
To compare the efficacy of pegilodecakin in combination with pembrolizumab ...
Status
Terminated
Location
CCI - Clearview Cancer Institute
Start Date
2018-03-19
Trial ID
NCT03382899
Treatments Being Tested
The purpose of this study is to assess the prevalence of pre-treatment tumo...
Status
Completed
Location
Research Site
Start Date
2019-01-17
Trial ID
NCT03788746
This is an open-label, multi-centre, umbrella Phase II study in participant...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-12-18
Trial ID
NCT03334617
Treatments Being Tested
To characterize and quantify immune cells expressing the Interleukine 4 ind...
Status
Completed
Location
Dermatology department
Start Date
2022-04-12
Trial ID
NCT04253080
Treatments Being Tested
Open Label, Phase 1 study of CD19 t-haNK as a single agent and combination ...
Status
Active Not Recruiting
Location
FARMOVS
Start Date
2024-08-23
Trial ID
NCT06334991
Treatments Being Tested